Table 2 Baseline statistical description of patients with CRC
From: Building a knowledge base for colorectal cancer patient care using formal concept analysis
Characteristic | N (%) |
|---|---|
Age (years) | Â |
< 60 | 1108 (45.4) |
60–70 | 824 (33.7) |
≥ 70 | 510 (20.9) |
Cell differentiation | Â |
moderate | 425 (17.4) |
poor | 1878 (76.9) |
well | 139 (5.7) |
Histological type | Â |
Mucinous adenocarcinoma | 327 (13.4) |
Adenocarcinoma | 2115 (86.6) |
Lymph nodes | Â |
< 10 | 224 (9.2) |
≥ 10 | 2218 (90.8) |
CEA (ÎĽg/ml) | Â |
< 5 | 1487 (60.9) |
≥ 5 | 955 (39.1) |
CA19-9 (U/ml) | Â |
< 37 | 2100 (86.0) |
≥ 37 | 342 (14.0) |
Lymphovascular invasion | Â |
Yes | 109 (4.5) |
No | 2333 (95.5) |
LNR | Â |
< 0.13 | 1779 (72.9) |
≥ 0.13 | 663 (27.1) |
T stage | Â |
T1 | 128(5.2) |
T2 | 388(15.9) |
T3 | 592(24.2) |
T4 | 1334(54.6) |
N stage | Â |
N0 | 1489(61.0) |
N1 | 533(21.8) |
N2 | 420(17.2) |
Cancer stage group | Â |
I | 428 (17.5) |
IIA | 396 (16.2) |
IIB | 648 (26.5) |
IIC | 17.0 (0.7) |
IIIA | 66.0 (2.7) |
IIIB | 530 (21.7) |
IIIC | 357 (14.6) |